Lung cancer: Low-dose CT screening-determining the right interval

Nature Reviews Clinical Oncology

Volumn 13, Issue 9, 2016, Pages 533-534

  Yankelevitz, David ^a   Henschke, Claudia ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; HUMAN; MORTALITY RATE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RADIATION DOSE; RISK ASSESSMENT; SHORT SURVEY; SMOKING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; MASS SCREENING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84978138209     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2016.106     Document Type: Short Survey

References (6)

1. [No authors listed] Lung cancer: screening. US Preventive Services Task Force http://www. uspreventiveservicestaskforce.org/Page/Document/ UpdateSummaryFinal/lung-cancer-screening (2015).
2. Patz, E. F. et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol. 17, 590-599 (2016).
3. Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395-409 (2011).
4. Henschke, C. I. et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 263, 578-583 (2012).
5. Yankelevitz, D. F. & Smith, J. P. Understanding the core result of the National Lung Screening Trial. N. Engl. J. Med. 368, 1460-1461 (2013).
6. Miettinen, O. S. et al. Mammographic screening: no reliable supporting evidence? Lancet 359, 404-405 (2002).